Ovid (OVID) shares surge 92% after soticlestat deal with Takeda in rare epilepsy syndromes
March 03 2021 - 7:21AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Apr 2023 to Apr 2024